Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease.
about
Cigarette Smoke Amplifies Inflammatory Response and Atherosclerosis Progression Through Activation of the H1R-TLR2/4-COX2 AxisWnt5a is expressed in murine and human atherosclerotic lesionsCommon genetic variation, residential proximity to traffic exposure, and left ventricular mass: the multi-ethnic study of atherosclerosis.Atherogenesis and iron: from epidemiology to cellular level.Hypaphorine Attenuates Lipopolysaccharide-Induced Endothelial Inflammation via Regulation of TLR4 and PPAR-γ Dependent on PI3K/Akt/mTOR Signal Pathway.DC-SIGN and Toll-like receptor 4 mediate oxidized low-density lipoprotein-induced inflammatory responses in macrophagesRole of Toll-like receptors 2 and 4 in the induction of cyclooxygenase-2 in vascular smooth muscle.Zinc and regulation of inflammatory cytokines: implications for cardiometabolic diseasePlatelet response as a sentinel marker of toll-like receptor 4 activation in mice.Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels.Low level bacterial endotoxin activates two distinct signaling pathways in human peripheral blood mononuclear cells.Association of blood monocyte and platelet markers with carotid artery characteristics: the atherosclerosis risk in communities carotid MRI study.EPA and DHA exposure alters the inflammatory response but not the surface expression of Toll-like receptor 4 in macrophagesWnt5a, TLR2 and TLR4 are elevated in advanced human atherosclerotic lesions.Toll-like receptor 4 mediates inflammatory cytokine secretion in smooth muscle cells induced by oxidized low-density lipoprotein.Genetics of stress response and stress-related disorders.TLR4/NF-κB signaling contributes to chronic unpredictable mild stress-induced atherosclerosis in ApoE-/- mice.Thematic review series: The immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis.Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studiesToll-like Receptors in the Vascular System: Sensing the Dangers Within.Race and gender variation in response to evoked inflammationImpact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in miceFunctional consequences of toll-like receptor 4 polymorphisms.Genetic variation and atherosclerosis.Toll-like receptors, transduction-effector pathways, and disease diversity: evidence of an immunobiological paradigm explaining all human illness?Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome.Effects of chronic mild stress on the development of atherosclerosis and expression of toll-like receptor 4 signaling pathway in adolescent apolipoprotein E knockout mice.Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overviewToll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats.MicroRNAs as potential biomarkers of smoking-related diseases.Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential.Association between Toll-like receptor 4 Asp299Gly polymorphism and coronary heart disease susceptibility.Relation between TLR4/NF-κB signaling pathway activation by 27-hydroxycholesterol and 4-hydroxynonenal, and atherosclerotic plaque instability.Comparison of anti-endotoxin activity of apoE and apoA mimetic derivatives of a model amphipathic peptide 18A.Phenylmethimazole blocks dsRNA-induced IRF3 nuclear translocation and homodimerization.miR-223 Inhibits Lipid Deposition and Inflammation by Suppressing Toll-Like Receptor 4 Signaling in Macrophages.Repulsive guidance molecule a blockade exerts the immunoregulatory function in DCs stimulated with ABP and LPSElaidate, an 18-carbon trans-monoenoic fatty acid, but not physiological fatty acids increases intracellular Zn(2+) in human macrophages.Enhanced TLR4 endothelial cell immunohistochemical expression in symptomatic carotid atherosclerotic plaques.Polymorphism -2604G>A variants in TLR4 promoter are associated with different gene expression level in peripheral blood of atherosclerotic patients.
P2860
Q26776119-5FD68832-BC5D-47D9-8536-58599E62552BQ28278954-706D3DA8-C443-4AC8-8BB7-0A633EB2354BQ30435119-F5A75107-6F37-4F53-938C-10AE94B1ADB0Q33595279-E88961FB-1921-44C4-ADD2-5A24BDC57B5BQ33624829-0F35E7F6-0BC4-499E-B01C-192ADD475EB8Q33789568-94A2A845-00C6-40B2-90E4-77D91DDE97D4Q33934368-939FEEEF-1B99-455B-B95D-107D5CEEE39DQ34291746-F4C7B263-D739-455D-B2EC-1CAD78C9ACFFQ34298384-3819F536-21B2-4553-AB40-7AC2B256CC9AQ34534979-800BA868-2717-4613-AC53-05B8D542F48AQ34668154-6F123347-AFCF-46A4-B6E7-42F5D18DCCAEQ34898589-6BCD80F8-A92C-4638-ABC2-4E8305ACB789Q35013976-A491EB25-BC9A-4613-9255-91F1AE4D1617Q35068901-1943F6DF-1822-4549-97D1-7082FDE588E9Q35154870-413A964C-F14B-4B82-A0A7-C131FF885349Q35236890-8A6795EF-959F-47B5-BA94-1C95510A94A2Q35364724-2248468C-12BA-4FC8-B4F8-EB6F31EB6206Q36011463-C698908B-5750-4561-8C3D-334119D637C5Q36013878-B9A1CDC6-DEE1-41C6-BE7D-4078EA42B157Q36453194-FFAC921F-7448-4781-8BB0-85EE5CB6374FQ36794209-C16B19B1-E129-4AB3-B0CC-BDB2113D10B1Q37042467-E2623D83-9548-4A7F-B3A9-80954220BD7BQ37071610-62A15420-BE7F-4289-B4C3-3E5D26CE2739Q37172163-DE17C9CE-746F-49E7-B030-AA507404383CQ37198685-B2A47ABF-1CEA-44B9-8668-CED965A6053EQ37283036-6B8CC942-5F3C-48A0-A069-4C1AAA14B2D7Q37326042-E637EE8F-6020-4082-8433-A237B4370D09Q37438144-92D2431A-0880-4AA5-B2C9-C2998590495BQ37731722-B763E75F-0CCD-4CAA-8E39-092D54CF2C6BQ38052928-0E6C98A5-CE85-4F7D-8948-4C68AB6281F0Q38620803-924F6361-D07A-4C89-8EE1-B6C090CEA719Q38632199-8BAA3F38-E905-4561-B234-969B09078C82Q38901560-7C030694-601F-4E35-8B4D-2F7794C6A7D4Q39045016-B6CA6EC7-4731-4D19-945A-888CD9648575Q39254888-916DE31F-855E-40D3-8953-EF4C6485A6D1Q40402994-E90B6B7C-458B-445E-BCE4-F0CE22ECACA0Q41369735-90BE035C-F873-43B1-8EAD-4B1A1788FBE2Q41501038-39496CEB-F042-44F8-BD7F-76BA03C8A87FQ43225863-439B10CE-0B8B-4748-BA56-68203F452788Q44504933-B11CB421-CF9B-4DB0-900A-D7952A132A2E
P2860
Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Role of Toll-like receptor 4 i ...... on of atherosclerotic disease.
@ast
Role of Toll-like receptor 4 i ...... on of atherosclerotic disease.
@en
type
label
Role of Toll-like receptor 4 i ...... on of atherosclerotic disease.
@ast
Role of Toll-like receptor 4 i ...... on of atherosclerotic disease.
@en
prefLabel
Role of Toll-like receptor 4 i ...... on of atherosclerotic disease.
@ast
Role of Toll-like receptor 4 i ...... on of atherosclerotic disease.
@en
P2093
P2860
P1476
Role of Toll-like receptor 4 i ...... on of atherosclerotic disease.
@en
P2093
De Kleijn DP
Pasterkamp G
Van Keulen JK
P2860
P304
P356
10.1111/J.1365-2362.2004.01338.X
P577
2004-05-01T00:00:00Z